Bentham Science Logo

Track Your Manuscript:

Current Drug Targets

Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access


Current Drug Targets, Volume 17 - Number 2

The Role of JNK Signalling in Responses to Oxidative DNA Damage

, 17(2): 154 - 163

Zeeshan Shaukat, Dawei Liu, Rashid Hussain, Mahwish Khan and Stephen L. Gregory

DOI: 10.2174/1389450116666150126111055

Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance

, 17(2): 164 - 177

Gabriela Nestal de Moraes, Laura Bella, Stefania Zona, Matthew J. Burton and Eric W.-F. Lam

DOI: 10.2174/1389450115666141122211549

Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions

, 17(2): 206 - 228

Rakesh Raj, Pooja Mongia, Suresh Kumar Sahu and Alpana Ram

DOI: 10.2174/1389450116666150722141607

The Use of Mesenchymal Stem Cells for the Treatment of Autoimmunity: From Animals Models to Human Disease

, 17(2): 229 - 238

Alessandra Fierabracci, Andrea Del Fattore, Marta Muraca, Domenico Vittorio Delfino and Maurizio Muraca

DOI: 10.2174/1389450116666150722140633


Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog